qo_q3_2019_1024x768_kvp
Quarterly Outlook

Localisation, Trump & Covid-19: the best things to ever happen to China

Kay Van-Petersen
Global Macro Strategist

Summary:  Adversity will take China's 2025-2035 plans, which are all about technology, moving up the value chain and developing tech infrastructure, and bring them forward

The current focus going into Q3 is the staggering disconnect between the damage that we have seen globally from Covid-19 – economically, socially, politically and from a humanitarian perspective – and the market response. 

While the economic contractions, close-to-standstill activity and job losses across so many metrics have seen multi-decade records broken (i.e. unemployment or economic growth), listed asset classes have only soared higher. Some indices, such as the NASDAQ, have hit all-time highs.  

As an experienced volatility trader (codename Vega) made clear on a recent macro group call: “make no mistake, this is the worst economic time of your life”, so perhaps we shouldn’t use the level of the equity market as a barometer for the system’s underlying health, fractures and potential breaks. It’s worth noting that this was someone who made +50% in Q1 – they are very cognisant of the disconnect between asset prices and the underlying fundamentals in the economy.  

There will be some natural low-hanging fruit and pent-up demand as the world reopens fully, but there will also be risks: from second-wave infections, further lockdowns and more. As cited often on the Macro Dragon, my take is that the probability of another co-ordinated global shutdown is almost 0% – the costs economically, politically and from a stability standpoint are just too high for almost all countries.  

What we can say with high probability is that the monetary and fiscal policies of the world will keep the accelerator pushed down on loose and accommodative policies for a long time. Liquidity is currently the primary driver in regards to the ascent of listed asset prices, with fundamentals gagged and bound in the boot of the car. At some point this will reverse, but it could be 6-18 months or even years away. After Abenomics, the Nikkei went up circa +150% over 3 years.  

The key global backdrop on all this however – predominantly brought to light by the Trump administration, but now globally in vogue and almost certain to continue even in a Biden presidency –  is localisation, the inverse of globalisation.  
China is facing the perfect storm of adversity and challenges, including the costs of Covid-19, US-China relations deteriorating, the west backing Hong Kong over Beijing and, still to come, a global backlash that is only set to increase once the Covid dust settles on who is to blame for all this (think Occupy Wall Street x 1,000).  

Adversity, though, will only make a country more resilient and innovative, forcing it to tap into its true potential. Trump and Covid-19 are going to be the best things that have happened to China – a function of which will spill net positive to the rest of the world – in that it will accelerate Beijing’s plans to go from being export dependent to domestic-consumer driven. It will take China’s 2025-2035 plans, which are all about technology, moving up the value chain and developing tech infrastructure, and bring them forward. Finally, it will open China’s markets and accelerate reform which has been held back by export dependency.  

Overall, localisation will raise global competition. Globalisation lowers global competition: why innovate, when you can just find a lower-cost producer?  

The likely net result of a more localised and domestic-consumer-driven China is:  

  • Breakthroughs in AI and autonomous vehicles on a scale that no other country can match 
  • Innovation and application of renewable technology (think Next-Gen nuclear plants) 
  • Growth in Chinese domestic tourism, plus the overall hospitality and travel industry  
  • China Govies and credit 
  • Chinese tech plays (long undervalued and underperforming against US tech) 
  • Hong Kong being a contrarian play (don’t want Chinese companies to list in the US? Fine, no problem, they can list at home be it Hong Kong or Shanghai)  
  • China upping their game on investor protection, governance and rule of law to attract foreign capital  

There will be a huge opportunity cost for the countries that choose to ignore dealing with 1.4 billion consumers and an economy that will become the largest in the world in most people’s lifetime. This opportunity cost will be an opportunity boon to others – such as Germany and the eurozone as a whole – who will capitalise by pivoting further towards China. 

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.